These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
309 related articles for article (PubMed ID: 23966419)
1. Genetic alterations in thyroid tumors from patients irradiated in childhood for tinea capitis treatment. Boaventura P; Pereira D; Celestino R; Mendes A; Nakasawa T; Teixeira-Gomes J; Sobrinho-Simões M; Soares P Eur J Endocrinol; 2013 Nov; 169(5):673-9. PubMed ID: 23966419 [TBL] [Abstract][Full Text] [Related]
2. PAX8-PPARgamma rearrangement is frequently detected in the follicular variant of papillary thyroid carcinoma. Castro P; Rebocho AP; Soares RJ; Magalhães J; Roque L; Trovisco V; Vieira de Castro I; Cardoso-de-Oliveira M; Fonseca E; Soares P; Sobrinho-Simões M J Clin Endocrinol Metab; 2006 Jan; 91(1):213-20. PubMed ID: 16219715 [TBL] [Abstract][Full Text] [Related]
3. Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma. Zou M; Baitei EY; Alzahrani AS; BinHumaid FS; Alkhafaji D; Al-Rijjal RA; Meyer BF; Shi Y Thyroid; 2014 Aug; 24(8):1256-66. PubMed ID: 24798740 [TBL] [Abstract][Full Text] [Related]
4. Molecular Profiling of Papillary Thyroid Carcinoma in Korea with a High Prevalence of BRAF Lee SE; Hwang TS; Choi YL; Kim WY; Han HS; Lim SD; Kim WS; Yoo YB; Kim SK Thyroid; 2017 Jun; 27(6):802-810. PubMed ID: 28293988 [TBL] [Abstract][Full Text] [Related]
5. Genotyping of an Italian papillary thyroid carcinoma cohort revealed high prevalence of BRAF mutations, absence of RAS mutations and allowed the detection of a new mutation of BRAF oncoprotein (BRAF(V599lns)). Carta C; Moretti S; Passeri L; Barbi F; Avenia N; Cavaliere A; Monacelli M; Macchiarulo A; Santeusanio F; Tartaglia M; Puxeddu E Clin Endocrinol (Oxf); 2006 Jan; 64(1):105-9. PubMed ID: 16402937 [TBL] [Abstract][Full Text] [Related]
6. Fusion Oncogenes Are the Main Genetic Events Found in Sporadic Papillary Thyroid Carcinomas from Children. Cordioli MI; Moraes L; Bastos AU; Besson P; Alves MT; Delcelo R; Monte O; Longui C; Cury AN; Cerutti JM Thyroid; 2017 Feb; 27(2):182-188. PubMed ID: 27849443 [TBL] [Abstract][Full Text] [Related]
8. RET/PTC and PAX8/PPARγ chromosomal rearrangements in post-Chernobyl thyroid cancer and their association with iodine-131 radiation dose and other characteristics. Leeman-Neill RJ; Brenner AV; Little MP; Bogdanova TI; Hatch M; Zurnadzy LY; Mabuchi K; Tronko MD; Nikiforov YE Cancer; 2013 May; 119(10):1792-9. PubMed ID: 23436219 [TBL] [Abstract][Full Text] [Related]
9. Trisomy 17 as a marker for a subset of noninvasive thyroid nodules with focal features of papillary carcinoma: cytogenetic and molecular analysis of 62 cases and correlation with histological findings. Frau DV; Lai ML; Caria P; Dettori T; Coni P; Faa G; Morandi L; Tallini G; Vanni R J Clin Endocrinol Metab; 2008 Jan; 93(1):177-81. PubMed ID: 17956956 [TBL] [Abstract][Full Text] [Related]
10. Detection of PAX8/PPARG and RET/PTC rearrangements is feasible in routine air-dried fine needle aspiration smears. Ferraz C; Rehfeld C; Krogdahl A; Precht Jensen EM; Bösenberg E; Narz F; Hegedüs L; Paschke R; Eszlinger M Thyroid; 2012 Oct; 22(10):1025-30. PubMed ID: 23025542 [TBL] [Abstract][Full Text] [Related]
11. Concomitant BRAF(V600E) mutation and RET/PTC rearrangement is a frequent occurrence in papillary thyroid carcinoma. Guerra A; Zeppa P; Bifulco M; Vitale M Thyroid; 2014 Feb; 24(2):254-9. PubMed ID: 23806056 [TBL] [Abstract][Full Text] [Related]